Salmonella enterica servovar Typhimurium is capable of targeting, colonizing, and eliciting growth suppression of tumors in mice. We examined the effects of mutations on this anticancer phenotype in two Salmonella virulence gene clusters. Salmonella pathogenicity island ( SPI ) -1 genes promote systemic invasion from the intestine, whereas SPI -2 genes support systemic survival within macrophages and other cells. Disabling SPI -1 ( prgH À ) strongly reduced invasion in vitro, but had no effect on tumor growth suppression in vivo. However, disabling SPI -2 ( ssaT À ) ablated tumor growth suppression. In addition to ssaT À , mutations in SPI -2 genes sseA, sseB, sseC, sscA, and ssrA also eliminated antitumor activity, whereas mutations in sseF or sseG yielded partial loss of function. Impaired tumor amplification was seen in three SPI -2 mutants tested after intravenous or intratumoral injection. A SPI -2 À strain was unable to suppress tumor growth in CD18 -deficient mice with defective macrophages and neutrophils, suggesting that loss of tumor growth suppression in wild -type mice by SPI -2 mutants was not solely a function of increased susceptibility to immune attack. Thus, SPI -2 is essential for the Salmonella antitumor effects, perhaps by aiding bacterial amplification within tumors, and is the first identified genetic system for this Salmonella phenotype.
G enetically engineered, attenuated strains of Salmonella enterica servovar Typhimurium have many of the desirable properties of a tumor delivery vector, including targeting of tumors from a distant inoculation site, selective replication within tumors, tumor growth suppression, 1 -3 and the ability to express effector genes such as those encoding the herpes simplex thymidine kinase, 1, 4 Escherichia coli cytosine deaminase, 5 and tumor necrosis factor (TNF ). 6 Lipid A -modified (msbB À ) salmonellae auxotrophs ( purI À ) that were attenuated for toxicity in mice and swine were developed. 7 These mutants showed significantly reduced host TNF induction, yet retained the abilities for tumor-targeting, amplification, and growth suppression in mice, achieving tumor accumulations of 10 9 -10 10 colonyforming units ( cfu ) /g tumor with tumor-to -normal tissue ratios exceeding 1000:1. However, little is known about the mechanisms through which salmonellae exert their anticancer effects. Specifically, what roles, if any, might the known Salmonella virulence factors play in these processes? S. enterica servovar Typhimurium is thought to contain about 200 genes for virulence factors, encoded on five pathogenicity islands, smaller pathogenicity islets, at least one virulence plasmid, and other chromosomal sites. 8 -11 The bacteria contain at least two type III secretion systems ( TTSS ). One (Inv /Spa ) is located in Salmonella pathogenicity island ( SPI )-1 and controls bacterial invasion of epithelial cells. 12, 13 The other is located in SPI -2 where it plays a crucial role in systemic growth in its host and is required for survival within macrophages. 14 -18 Thus, in an attempt to better understand the bacterial antitumor phenotype, we analyzed the effects of mutations in SPI -1 and SPI -2 virulence genes on bacterial growth suppression of B16F10 melanomas in C57B6 mice. The results indicate that expression of SPI -2, but not SPI -1, is essential for the antitumor effects, at least in part by aiding bacterial targeting of, and amplification within, tumors.
Materials and methods

Bacteria
Three S. enterica servovar Typhimurium parental strains ( all derived from ATCC 14028 ) were employed in these studies: YS7212, 1 YS1456, 7 and YS1646 ( VNP20009 ). 3, 7 All three carry attenuating auxotrophic mutations, and YS1456 and YS1646 carry further attenuating msbB À (altered lipid A ) mutations whereas YS7212 carries msbB + . All three strains showed similar tumor targeting, amplification, and growth suppression when injected intravenously (i.v. ) into tumorbearing mice. The SPI-1 TTSS mutation used was prgH::TnphoA ( Kan -r ) from strain IB040. 19 The SPI -2 TTSS mutation was ssaT::mTn5 (Kan -r) from strain P9B7. 16 We transferred the mutations to our own strains using P22 -mediated transduction. 20 Knock-out mutations in SPI -2 genes sscA, sseA, sseB, sseC, sseF, sseG, and ssrA were transduced into YS1646 from strains P10E11, HH100, HH102, HH104, HH107, HH108, 15 and P3F4, 16 respectively, selecting kanamycin resistance.
In vitro invasion and intracellular replication assays
Invasion assay. Cloudman S91 or B16F10 melanoma cells were grown in 12-well Corning tissue culture plates to a density of approximately 2Â10 4 cells /well. Salmonellae were grown to late log phase ( OD 600 = 0.9) in Luria -Bertani ( LB ) broth to induce SPI-1 invasion genes, 21 diluted in prewarmed melanoma culture medium (DMEM/ 10% fetal bovine serum ), added to the melanoma cells (10 5 cfu /mL ), and placed in a gassed, humidified incubator at 378C. After 15 minutes, the melanoma cultures were rinsed and incubated for an additional 1 hour in medium containing gentamycin sulfate (100 g /mL ) to kill external, but not internal, bacteria. 1, 22 The infected melanoma cells were then rinsed free of the antibiotic, harvested, plated onto LB agar plates, and bacterial colonies counted after growth overnight at 378C. Intracellular replication assay. The initial procedures for measuring intracellular replication were the same as those above for invasion, except that incubation of melanoma cells with salmonellae was increased to 30 -60 minutes before the addition of gentamycin, and intracellular salmonellae were quantitated at designated time points over 24 hours in the continued presence of gentamycin.
Tumor implantation and Salmonella injection into mice C57B6 or C57B6 CD18 -deficient 23 ( Jackson Laboratories, Bar Harbor, ME ) female mice 6 -8 weeks were implanted subcutaneously ( s.c. ) on the mid -right side with 5Â10 5 B16F10 cells using a 19-gauge needle. Bacterial injections were with a 30-gauge needle as follows.
Intratumoral ( i.t. ) injections. Bacteria were grown overnight on LB agar plates and then diluted in 0.9% NaCl and injected directly into the center areas of tumors, using three separate sites with injections of 50 L each for a total of 150 L and 10 5 cfu per tumor.
I.v. injections. Bacteria were grown and diluted as above and injected into the lateral tail vein (2Â10 5 cfu /0.1 mL of saline).
Quantitation of salmonellae in tumors
Tumor aspiration method. Tumors were repeatedly sampled at the times noted by pooling three measured aspirates ( 50-100 L ) taken from the tumor centers with a 23 -gauge needle, and plating serial dilutions onto LB agar plates. Tumors were measured with calipers as described below.
Tumor homogenization method. At designated times postbacterial injection, the animals were sacrificed, and the tumors removed and weighed. The tumor was homogenized in 5 vol of LB broth per gram of wet weight tumor and quantitated for bacteria by serial dilution on LB agar plates.
Tumor growth
Tumor measurements were taken with Mitutoyo Digimatic Calipers connected to an Apple PowerBook 1 computer. Volume was calculated and data were processed and graphed with the Scriptable Text Editor and AppleScript 2 software from Apple Computer. Formula volume =LWHÂ0.52 was used for volume calculations. When data were presented as cfu per gram of tumor, we used the approximation of 1000 mm 3 = 1 g of tumor. Effects of treatments on tumor growth were expressed either as mean tumor volumes ± SE versus time (d ), or as time (d ) for tumors to reach 1 g, or as survival ( tumor !2 g) by Kaplan -Meier analyses. 24 
Statistics
Means and standard errors were calculated according to standard formulas with AppleScript 2 software (Cupertino, CA ). Curve fitting was done with Cricket Graph III 1 from Computer Associates ( Islandia, NY ). P value calculations were done using Student's t -test with StatView 1 software from Abacus Concepts (SAS Institute, Cary, NC ).
Animal welfare and euthanasia
All experimental protocols were approved by the Yale University Animal Care and Use Committee. CO 2 was used for mouse euthanasia, consistent with the recommendations of the Panel on Euthanasia of the AVMA. Animals were euthanized when tumors reached 2 g, or sooner if they showed signs of distress ( cessation of eating and drinking, weight loss, listlessness ). Yale University is registered as a research facility with the United States Department of Agriculture. The School of Medicine is fully accredited by the American Association for Accreditation of Laboratory Animal Care. An Animal Welfare Assurance is on file with OPRR -NIH.
Results
SPI -1 and SPI -2 mutations and tumor growth suppression
All experiments were carried out with S. enterica servovar Typhimurium wild -type strain 14028 and derivatives thereof as described in Materials and Methods. The first experiments were to determine potential roles for SPI -1 and /or SPI-2 gene expression in tumor growth suppression. We examined the effects of mutations in prgH 25 and ssaT 16 that disable the SPI -1 and SPI -2 TTSS, respectively. In vitro invasion assays confirmed that the prgH mutation caused >100 -fold reductions in the ability to invade mammalian cells, whereas the ssaT mutation showed only a modest (25 -77%) reduction in invasion (Table 1) . (These results with SPI-2 are consistent with previous studies showing that some SPI -2 mutations affect SPI -1-mediated invasion. 26, 27 ) The effects of the above mutations on suppression of B16F10 melanoma tumor growth are shown for salmonellae strains YS1646, YS1456, and YS7212 (Fig 1, A -C ) . In all three cases, the prgH mutation had no significant effect whereas the ssaT mutation eliminated tumor growth suppression. Thus, these first analyses of the two TTSS mutations in vivo indicated that the SPI -2 secretion system was necessary for tumor growth suppression, whereas that of SPI -1 was apparently not.
To further investigate the role of SPI -2 in tumor growth suppression, a number of mutant genes governing SPI -2 virulence functions in strain YS1646 were examined ( Fig 2 ) . Each panel shows the effects on tumor growth of a specific SPI -2 mutation versus the corresponding YS1646 SPI -2 + strain, compared to tumor growth in untreated mice. As expected, 3 the YS1646 SPI -2 + strain delayed tumor growth for almost 2 weeks compared to untreated controls, however, the YS1646 strains with mutations in translocon (and putative effector ) genes sseA, sseB, sseC, putative chaperone gene sscA, or regulatory gene ssrA were unable to delay tumor growth, and YS1646 with mutations in effector genes sseF and sseG elicited partial growth delay compared to the SPI -2 + counterpart. The results were similar in 2/2 tumor growth experiments, as could be seen when the ratios of treated to control values were compared as a function of the time in days for tumors to reach 1 g ( Table 2 ).
Effects of SPI -2
+ and SPI -2 À salmonellae on tumor growth in CD18 -deficient mice
The leukocytic integrin CD18 is crucial for the antimicrobial functions of macrophages and granulocytes, 23 and it was shown that CD18 -deficient mice are resistant to phagocytemediated dissemination of salmonellae to the liver and spleen after oral administration. 28 We reasoned that should the failure of SPI -2 mutations to suppress tumor growth in CD18 + mice be due to their increased susceptibility to macrophages and granulocytes, the antitumor functions might be restored in the CD18 -deficient mice. Therefore, the effects of SPI -2 + and SPI -2 À salmonellae on B16F10 melanoma tumor growth in C57B6 CD18 -deficient mice were investigated. Surprisingly, as with CD18 + mice, sseB À YS1646 was unable to suppress tumor growth, and thus unable to prolong survival in the CD18 -deficient animals.
On the contrary, sseB + YS1646 showed tumor growth suppression and prolonged survival comparable to that seen in the CD18 + animals ( Fig 3 ) .
SPI -2 mutations and bacterial amplification within tumors
To examine i.t. amplification, salmonellae were injected into B16F10 melanomas 20 days posttumor implantation when Invasion was carried out for 15 minutes as described ( Materials and methods ). Results are the mean ± SE for triplicate determinations, and the experiments were performed three times with similar results. *Statistical differences versus parental strains ( P < .010 ). + ; SPI -2 + strains, diamonds; prgH À ( SPI -1 ), triangles; ssaT À ( SPI -2 ), circles. Similar results were obtained in three separate experiments. SPI -1 mutant strains ( prgH À ), like their wildtype counterparts, were significantly different from saline -injected controls in tumor growth suppression ( P < .070 ), while SPI -2 mutants ( ssaT À ) showed no significant differences from saline controls ( P > .600 ). Data for statistical analyses were taken from tumor measurements on day 18 ( YS1646, YS1456 ) or 24 ( YS7212 ) post tumor implantation.
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Salmonella virulence genes and anticancer activity JM Pawelek et al the tumors were readily palpable (1 -2 g ). The data in Table  3 are from experiments where bacteria were injected i.t. ( 10 5 cfu /tumor ) and the same tumors were sampled repeatedly by needle aspiration over 7 days (Materials and methods ). The effects of sseB À , sseC À , and sseA À were investigated in strain YS1456. As expected, 3 SPI -2 + YS1456 amplified from the 10 5 cfu injected to 10 9 cfu / g tumor by 24 hours postinjection, and plateaued at 1 -2Â10 10 /g tumor by 3 days. In contrast, the sseB À mutant showed delayed i.t. amplification, which in three experiments ranged in retardations of 1-4 days before reaching wild -type levels. Likewise, sseA À and sseC À mutants showed similar impaired amplification ( shown ). None of the SPI -2 mutations affected bacterial growth in LB broth in vitro (not shown ). As described above, the results in Table 3 were obtained by repeated sampling of tumors that had been directly inoculated with bacteria. In experiments not shown, similar delays in amplification of 1456 sseB À were observed in tumors when bacteria were injected i.v. ( lateral tail vein ) Figure 2 Effects of mutations in SPI -2 genes sseA, sseB, sseC, sseF, sseG, sscA, ssaT, and ssrA on tumor growth suppression by Salmonella strain YS1646. Salmonellae ( 2Â10 5 cfu / mouse ) were injected i.v. into C57B6 mice 7 days post s.c. implantation of B16F10 melanoma cells, and tumor growth was monitored with electronic calipers ( Materials and methods ). Each panel shows the effects on tumor growth of a specific SPI -2 mutation ( diamonds ) versus the corresponding YS1646 SPI -2 + ( circles ), compared to tumor growth in untreated mice ( squares ). Data were not shown if one or more animals in a group had died. Points represent mean ± SE for n = 8 -10 mice / group. The experiment was repeated with similar results. See Table 2 for P values regarding statistical significance. 5 melanoma cells implanted per mouse. n = 7 -8 mice / group. Data were obtained by extrapolation of tumor growth curves ( Fig 1 ) . The days to 1 g are less overall in Experiment 2 compared to Experiment 1 because twice as many B16F10 melanoma cells were implanted in Experiment 2, causing the tumors to appear sooner.
*Statistical difference versus saline control ( P < .080 ). Data for statistical analyses were taken from tumor measurements on day 26 ( Experiment 1 ) or day 18 ( Experiment 2 ) post tumor implantation. Figure 3 Effects of an sseB À mutation on melanoma growth suppression by Salmonella strain YS1646 ( VNP20009 ) in C57B6 CD18 À mice ( n = 10 mice / group ). Results are shown as a KaplanMeier analysis of survival, 31 as defined by tumors reaching 2 g, when animals were euthanized ( Materials and methods ). The experiment was repeated with similar results. rather than i.t., and quantitation of tumoral bacteria levels in tumor homogenates was carried out 5 -9 days later.
Discussion
The results show that expression of the SPI -2 regulon is a requirement for the anticancer capabilities of S. enterica servovar Typhimurium in mice, including i.t. amplification and tumor growth suppression. Mutations in ssaT, sseA, sseB, sseC, sscA, and ssrA abolished tumor growth suppression, whereas those in sseF and sseG produced partial losses of this function. In accord with these findings on sseF and sseG, studies of systemic infections in mice revealed that mutations in sseF and sseG (as well as sseE ) did not result in significant attenuation of virulence, indicating that these genes may not be essential for the function of SPI -2, or that they have redundant functions. 14, 15 The impaired anticancer capabilities of SPI -2 mutants occurred in both msbB À ( YS1456, YS1646 ) and msbB + (YS7212) strains, indicating that the effects were independent of the msbB À mutation, which is characterized by altered lipid A. 7 Because delayed amplification of SPI-2 À salmonellae was observed even after direct i.t. injections, if attack from leukocytes were the cause of the impaired anticancer functions of these mutants, such attack occurred not only systemically but also within tumors, presumably through macrophages and possibly other tumor-infiltrating leukocytes (e.g., dendritic cells, neutrophils, lymphocytes ). It is also possible that factors other than immune attack were at play; however, bacterial cell division per se did not seem to be affected because SPI -2 mutations did not impair growth rates of these strains in LB broth (not shown ). Further, although it has been well established that loss of SPI -2 function impairs Salmonella replication within macrophages, 14, 15, 17, 18, 29 we found that sseB À , sseC À , and ssrA À mutants grew intracellularly in both B16F10 and Cloudman S91 melanoma cells at the same rate as the parental YS1646 strain ( not shown ). These experiments employed the gentamycin protection assay 18 ( Materials and methods ), and multiple time points were examined over 24 hours. The results were the same whether the bacteria were grown to late log phase, or were in stationary phase prior to invasion of melanoma cells, as discussed. 18 We cannot explain this unexpected lack of impaired replication by SPI -2 mutants in the melanoma cells; however, it may be related to recent observations of different intracellular trafficking pathways for Salmonella in melanoma cells and other skin -derived cells compared to macrophages. 30 It, thus, remains possible that SPI -2 gene expression had a direct, suppressive effect on tumor cells, as opposed to its known role in systemic survival. This was supported by the finding that sseB À salmonellae failed to suppress tumor growth even in CD18 -deficient mice with only 2 -16% of normal CD18 expression by granulocytes and macrophages ( Fig 3 ) . 23 These CD18 -deficient mice showed severely impaired inflammatory responses to chemical peritonitis and delayed rejection of cardiac transplants. 23 Further, these same mice were unable to accomplish systemic dissemination of salmonellae from the intestine, a phenomenon attributed to impaired phagocytic function. 28 Thus, the lack of tumor growth suppression by sseB À bacteria in CD18 À as well as CD18 + mice suggests that the impaired antitumor functions were not due to greater susceptibility of the SPI -2 mutants to immune attack; however. further studies are required in this area.
Although amplification of SPI -2 À strains in tumors was delayed, the mutants ultimately reached the high levels of 10 10 cfu / g tumor as did their SPI -2 + counterparts. A possible explanation for this phenomenon is that during the delay, SPI -2 + revertants arose within the tumors. In studies not shown, we analyzed bacteria isolated from three separate tumors following i.t. injection of strain YS1456 sseB À when the i.t. levels had reached >10 10 cfu /g tumor following a delay as shown in Table 3 . Like the originally injected YS1456 sseB À strain, the tumor isolates were pur À and msbB À and did not express the SseB protein, as analyzed by immunoblotting. 31 Thus, the i.t. amplification of YS1456 sseB À did not involve reversion to sseB + ; however, it could not be ruled out that mutations that were compensatory for sseB À arose, thus promoting amplification. Further studies are underway in this area.
In conclusion, the purpose of this study was to begin to understand the genetic basis of the S. enterica servovar Typhimurium anticancer phenotype. We found that a major virulence regulon necessary for systemic survival, SPI -2, is also necessary for the anticancer properties. The i.t. environment encountered by the bacteria is highly complex, presenting not only diverse physico-chemical barriers, but also tumor-infiltrating leukocytes with antimicrobial properties such as macrophages and neutrophils. The ability of the bacteria to survive and amplify in the midst of these barriers is key to its use as an anticancer vector. Although we have demonstrated that SPI -2 is intimately involved in these processes, the mechanisms of action remain unknown. We anticipate that further studies will continue to shed light on these highly complex molecular pathways through which Salmonella achieve their antitumor functions. Bacteria were injected i.t. into B16F10 melanomas in C57B6 mice 20 days post tumor implantation ( n = 9 -13 mice per group ). Tumor weights averaged 1 -2 g. Bacteria were quantitated over 7 days by repeated aspirations of tumors with a 26 -gauge needle ( Materials and methods ). The results are shown for sseB À derivatives; additionally, similar results were obtained for sseC À and sseA À derivatives ( not shown ). *Statistical difference for sseB + versus sseB À strains 24 hours post bacterial injections ( P < .070 ). Experiments were repeated three times, with delays in amplification for sseB À strains ranging from 1 to 4 days.
